Date: Monday, June 13, 2016
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Halls C&D
One-fifth of Medicare patients are readmitted to the hospital an annual cost of $17.4 billion. The LACE Index (Length of stay, Acuity of the admission, Co-morbidities, and Emergency department visits in the previous 6 months) is a validated tool for readmissions within 30 days. We tested this on liver transplant readmissions at a large liver transplant center.
Retrospective review of liver transplant recipients from 2012-2015 (N= 321) was performed. Patient deaths prior to discharge (N=12) and >30 day primary admissions (N=47) were excluded. The LACE index was calculated for all patients. MELD, discharge creatinine, white blood cell count, and demographic data were analyzed using ANOVA and Pearson Correlatysis.ion anal
76 patients (29%) were readmitted within 30-days. Readmits had slightly higher LACE scores (mean 11.6 vs 10.9, p=0.04). A LACE threshold >10 yielded a 35% readmission rate, compared to19% for <10 (p=0.01, sensitivity 76%, specificity 41%). LACE Index correlated with MELD, low WBC, female sex, and elevated creatinine. Other variables were not correlated to readmission rates.
The LACE index can help identify liver transplant patients at risk for 30-day readmission. Besides LACE, neither MELD nor other variables correlated with readmission. These data support the LACE Index as a valuable tool to intervene in patients identified at high-risk for readmission.
CITATION INFORMATION: Masoumi A, Barth R, LaMattina J, Bruno D, Hebert L, Schluterman N, Hanish S. LACE Index Risk Assessment Tool Predicts Liver Transplant Readmissions. Am J Transplant. 2016;16 (suppl 3).
To cite this abstract in AMA style:Masoumi A, Barth R, LaMattina J, Bruno D, Hebert L, Schluterman N, Hanish S. LACE Index Risk Assessment Tool Predicts Liver Transplant Readmissions. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/lace-index-risk-assessment-tool-predicts-liver-transplant-readmissions/. Accessed January 25, 2021.
« Back to 2016 American Transplant Congress